Video: Every Case Tells a Story| Webinar: ACR/CHEST ILD Guidelines in Practice

An official publication of the ACR and the ARP serving rheumatologists and rheumatology professionals

  • Conditions
    • Axial Spondyloarthritis
    • Gout and Crystalline Arthritis
    • Myositis
    • Osteoarthritis and Bone Disorders
    • Pain Syndromes
    • Pediatric Conditions
    • Psoriatic Arthritis
    • Rheumatoid Arthritis
    • Sjögren’s Disease
    • Systemic Lupus Erythematosus
    • Systemic Sclerosis
    • Vasculitis
    • Other Rheumatic Conditions
  • FocusRheum
    • ANCA-Associated Vasculitis
    • Axial Spondyloarthritis
    • Gout
    • Psoriatic Arthritis
    • Rheumatoid Arthritis
    • Systemic Lupus Erythematosus
  • Guidance
    • Clinical Criteria/Guidelines
    • Ethics
    • Legal Updates
    • Legislation & Advocacy
    • Meeting Reports
      • ACR Convergence
      • Other ACR meetings
      • EULAR/Other
    • Research Rheum
  • Drug Updates
    • Analgesics
    • Biologics/DMARDs
  • Practice Support
    • Billing/Coding
    • EMRs
    • Facility
    • Insurance
    • QA/QI
    • Technology
    • Workforce
  • Opinion
    • Patient Perspective
    • Profiles
    • Rheuminations
      • Video
    • Speak Out Rheum
  • Career
    • ACR ExamRheum
    • Awards
    • Career Development
  • ACR
    • ACR Home
    • ACR Convergence
    • ACR Guidelines
    • Journals
      • ACR Open Rheumatology
      • Arthritis & Rheumatology
      • Arthritis Care & Research
    • From the College
    • Events/CME
    • President’s Perspective
  • Search

REF Reaches for a Cure

David Holzman  |  Issue: September 2007  |  September 1, 2007

“I didn’t think I could do this when it was presented to me,” says Dr. Isaacs, clinical assistant professor of internal medicine at the University of North Texas Health Science Center in Fort Worth. But her patients who are able to contribute to WOR have taken great satisfaction in doing so, she says.

To date, about $1.3 million has been raised from patients by the ambassadors. Overall, the campaign has raised $18 million toward the $30 million goal.

ad goes here:advert-1
ADVERTISEMENT
SCROLL TO CONTINUE

“Within Our Reach” is the biggest grant program within the REF, although it offers many other grant opportunities for physicians and health professionals (see “Apply for REF Grants,” below). Its mission is “to promote the future of rheumatology by supporting and attracting terrific people into the field,” says Dr. O’Dell, through the core values of “supporting training, early career development, and research.” Even medical students and health professionals in training can apply for research funding. “We take seriously the recruitment of gifted medical students and residents into rheumatology,” says Dr. O’Dell.

David Holzman is a freelance writer based in Massachusetts.

ad goes here:advert-2
ADVERTISEMENT
SCROLL TO CONTINUE

Page: 1 2 3 | Single Page
Share: 

Filed under:ConditionsFrom the CollegeResearch RheumRheumatoid Arthritis Tagged with:ACR Research and Education Foundation (REF)Basic researchClinical researchGrantsREFResearchRheumatoid arthritisRheumatoid Arthritis (RA)translational researchWithin Our Reach

Related Articles

    Rheumatology’s Architect

    March 1, 2008

    Help the REF lay foundations for our future

    A Look Back & A Look Ahead: ACR Research and Education Foundation Turns 25

    August 1, 2010

    The ACR Research and Education Foundation turns 25

    Productive Partnership

    August 1, 2009

    The ACR and the REF work closely to support the future of rheumatology

    Partners in Advancing Rheumatology

    August 8, 2012

    The REF is making great strides in advancing treatment and finding cures for rheumatic disease.

  • About Us
  • Meet the Editors
  • Issue Archives
  • Contribute
  • Advertise
  • Contact Us
  • Copyright © 2025 by John Wiley & Sons, Inc. All rights reserved, including rights for text and data mining and training of artificial technologies or similar technologies. ISSN 1931-3268 (print). ISSN 1931-3209 (online).
  • DEI Statement
  • Privacy Policy
  • Terms of Use
  • Cookie Preferences